BDBM742454 4-methyl-5- [[2-[6-(2,2,2- trifluoroethyl) quinazolin-4-yl]-2,7- diazaspiro[3.5]nonan- 7-yl]methyl]-1-[[3- (1,1,4-trioxo-1,2,5- thiadiazolidin-2-yl)-1- bicyclo[1.1.1] pentanyl] methyl]indole-2- carbonitrile Example 63::US20250163061, Compound 62

SMILES Cc1c(CN2CCC3(CC2)CN(c2ncnc4ccc(CC(F)(F)F)cc24)C3)ccc2c1cc(C#N)n2CC12CC(N3CC(=O)NS3(=O)=O)(C1)C2

InChI Key InChIKey=LHJZNXYZDNHUFY-UHFFFAOYSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 742454   

TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742454(4-methyl-5- [[2-[6-(2,2,2- trifluoroethyl) quinazo...)
Affinity DataEC50: <75nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/19/2025
Entry Details
Go to US Patent